The Future of Sensors in the Diagnosis and Monitoring of Glaucoma

Dr Ridia Lim , Marlene R Moster, MD

Meeting:  2018 RANZCO


Date:      -

Session Title: Lecture- Glaucoma Update

Session Time:      -

Glaucoma is the second leading cause of blindness worldwide. It has been estimated that by 2020 there will be approximately 80 million people with glaucoma, an increase of about 20 mil- lion since 2010 – (World Health Organization data, 2018). Furthermore, it is thought that at pre- sent over 8 million people are bilaterally blind due to glaucoma, a figure that is set to rise to over 11 million by 2020 with the increasing prevalence, unless improved screening and effective treat- ment strategies are successful. The MIGS (minimally invasive glaucoma surgery) revolution may play a positive role in treating glaucoma at an earlier stage as the surgery may afford less risk with acceptable efficacy. However, even with easier access to these miniature shunts or devices, it is still difficult to know what the individual’s pressure is at different times of the day which is critical to controlling this disease. What happens to the intraocular pressure at night, with exer- cise and with different medications? An answer to this dilemma is to surgically place and intra- ocular sensor in the eye to monitor the IOP and finally answer the question “What really is my intraocular pressure?” This lecture will focus on the evolution of intraocular pressure monitoring and how sensors will affect the way we practice ophthalmology in the near future.